Abstract: 
INTRODUCTION
Garidi-5 has been used in traditional Mongolian medicine as an antibacterial and analgesic agent for treatments of various diseases including typhus, dyphteria, joint conditions, neurological and skin disorders. Garidi-5 is composed of 5 herbs including Terminalia chebula Retz., Aconitum Kusnezoffii Reichb., Acorus calamus L.,Saussurea lappa L., and musk of Moschus moschiferus. [1, 2] As written in traditional medical sourcebooks the compounds of Gairidi-5 mainly balance humors, detoxify the body, kill bacteria and relieve pain [3] . The drug has been studied chemical-pharmacological research. We have a new natural patch from the prepared Gardi-5.
In this study, using the carrageenaninduced rat paw pad edema model, we evaluated the anti-inflammatory effect of a 10% Gardi patch. The effect of the Gardi patch was compared to with commercially available 3.75% Ketoprofen-containing patches.
MATERIAL AND METHODS

Animals:
A total male 50 Wistar rats (180-220 g) were used for the study and all were housed in a quiet room with 12 h light/dark cycle. All experiments were approved by the Animal Studies Committee at Institute of Traditional medicine and technology of Mongolia.
Material: Gardi patch produced in of Institute of Traditional Medicine and Technology of Mongolia, was used in this study.
Anti-Inflammatory Study. Wistar male rats (aged 5 weeks) were measured for the volume of the right hind footpad paw in advance with the paw volume-measuring instrument, and 50 randomly selected rats were assigned to groups (10 animals in each group). The measured paw volumes were handled as the baseline values. In each study, a piece of drug patch was applied at the back center of the right hind footpad paw of each rat and fixed with Band-Aid.
During the treatment, the drug patch was removed at 2 hours after application, and 0.1 mL of an aqueous 1 w/v% suspension of λ-carrageenan in physiological saline was injected subcutaneously into the right hind footpad paw pad as an inflammationinducing agent. In the inflammation control group, no drug patch was applied, and only the inflammation-inducing agent was administered. At 0, 30, 60, 120, 180, 240, 300 minutes after the induction of inflammation, the paw volume was measured, and the edema rate (%) was calculated using the baseline value. Swelling of carrageenan injected foot was measured at 0, 30, 60, 120, 180, 240, 300 min using Plethysmometer (UGO Basile, Italy). Furthermore, efficacy of treatment with use of 1% carrageenan was found according to PGE2 and TNF α level. Blood samples were collected via cardiac puncture at 0, 30, 60, 120, 180, 240, 300 after the administration of carrageenan and from healthy rats.
All rats were euthanized with phenobarbital sodium before blood collection. The collected blood samples were centrifuged at 377.3 g for 10 min at 4°C, and the plasma supernatant was stored at -20°C until further analysis. The plasma levels of TNF-a and PGE2 were detected using solid-phase sandwich enzymelinked immune sorbent assay (ELISA, Shanghai MLBIO Biotechnology Co. Ltd.) kits specific for the detection of these factors, and the absorbance was measured at 450 nm by a plate reader (Chromate 4300 micro plate, Shanghai MLBIO Biotechnology Co. Ltd., China).
In the study used 10% (100 mg) Gardi patch, 3.5% (133 mg) Ketoprofen patch (Patex ® , Nipro Patch Co., Ltd). Since the density of each drug imbedded in the sheet differed, the applied dose was controlled by standardizing sheet size in this study at 2.0 cm × 1.75 cm, based on the relative difference between human and rat body sizes [4] [5] [6] .
Statistical analysis
Data are reported as means±SD. Statistical significance was determined by one-way analysis of variance followed by Tukey's multiple comparison test. A P value 0.05 was considered statistically significant.
RESULTS
Carrageenan induced rat paw edema
In the control group, the edema rate increased with time after induction of inflammation with a maximum at 5-6 hours ( Figure 1 ).
Figure 1. Anti-inflammatory effect (AUEC: Area under the effect curve) of 10% diclofenac patch or other NSAID patch on the carrageenan-induced hind footpad paw edema in rats
In the Gardi patch group, the edema rates were lower than those in the inflammation control group as well as in the Ketoprofen group from 1 hour after induction of inflammation, and a significant difference was seen between the Gardi patch group and the inflammation control group (p=0.009) at 6 hours after induction of inflammation.
Effect of Gardi patch on the expression of pro-inflammatory cytokines of plasma,
Effect of Gardi patch on the expression of pro-inflammatory cytokines of plasma. In the control group, the levels PGE2 significantly increased after carrageenan administration and reached peak levels at 300 min. However, the levels of the late stage proinflammatory cytokine TNF-a increased gradually and reached a peak at 60 min. In contrast, the rats treated with Gardi patch had significantly lower levels of PGE 2 (Carrageenan+Gardi patch group vs Carrageenan group: p=0.05 at 60, 120 and 240 min) and of TNF-a (p=0.05 at 120, 180, 240, and 300 min) (Figure 2 ). Statistical analysis revealed that Gardi patch and Ketoprofen significantly inhibited the development of edema 0-300 min after treatment (Fig. 2) and they both showed anti-inflammatory effects in Carrageenan induced rat paw edema.
DISCUSSION
This study was performed to evaluate the putative anti-inflammatory activities of Gardi patch, using various animal model to inflammation effects. The injection of Carrageenan into mice produces a typical biphasic edema associated with the production of several inflammatory mediators, including bradykinin, prostaglandins and cytokines. The first phase peaks at 3 h and the delayed phase peaks at 48 h after Carrageenan injection [7.8] . Development of edema induced by Carrageenan is commonly correlated with the early exudates stage of inflammation, which is one of the important processes of inflammatory pathology [9.10] .
It was found that the injection of Carrageenan into the mice paw induced the liberation of bradykinin, which later induced the biosynthesis of PGE2 and other autacoids that are responsible for the formation of the inflammatory exudates [11] [12] [13] [14] . We also evaluated the anti-inflammatory effects of Gardi patch on paw edema induced by Carrageenan in mice and detected the levels of TNF-α and PGE2 the paw edema 0-300 min after Carrageenan injection. It is clear from ( figure 2) .
Statistical analysis revealed that Gardi patch and Ketoprofen significantly inhibited the development of edema 0-300 min after treatment (Fig. 2) and they both showed antiinflammatory effects in Carrageenan induced rat paw edema. In the current study, the levels of TNF-α and PGE2 were decreased significantly of Gardi patch.
CONCLUSION
The results of this study showed that, in addition to the potent PGE2 and TNF α inhibiting activity and the Gardi patch was effective in decrease paw edema in Carrageenan induced rat paw edema model. Gardi patch has an anti-inflammatory effects.
